A calpain inhibitor protects against fractalkine production in lipopolysaccharide-treated endothelial cells

Published on Sep 30, 2017in Kidney research and clinical practice
· DOI :10.23876/j.krcp.2017.36.3.224
Jaewoong Jang6
Estimated H-index: 6
(CAU: Chung-Ang University),
Yoosik Yoon21
Estimated H-index: 21
(CAU: Chung-Ang University),
Dong-Jin Oh1
Estimated H-index: 1
Fractalkine (CX3CL1) is a chemokine with a unique CX3C motif and is produced by endothelial cells stimulated with lipopolysaccharide (LPS), tumor necrosis factor (TNF)-α, interleukin (IL)-1, and interferon-γ. There have been several reports that the caspase/calpain system is activated in endotoxemia, which leads to cellular apoptosis and acute inflammatory processes. We aimed to determine the role of the caspase/calpain system in cell viability and regulation of fractalkine production in LPS-treated endothelial cells.Human umbilical vein endothelial cells (HUVECs) were stimulated with 0.01-100 μg/mL of LPS to determine cell viability. The changes of CX3CL1 expression were compared in control, LPS (1 μg/mL)-, IL-1α (1 μg/mL)-, and IL-1β (1 μg/mL)-treated HUVECs. Cell viability and CX3CL1 production were compared with 50 μM of inhibitors of caspase-1, caspase-3, caspase-9, and calpain in LPS-treated HUVECs.Cell viability was significantly decreased from 1 to 100 μg/mL of LPS. Cell viability was significantly restored with inhibitors of caspase-1, caspase-3, caspase-9, and calpain in LPS-treated HUVECs. The expression of CX3CL1 was highest in IL-1β-treated HUVECs. CX3CL1 production was highly inhibited with a calpain inhibitor and significantly decreased with the individual inhibitors of caspase-1, caspase-3, and caspase-9.The caspase/calpain system is an important modulator of cell viability and CX3CL1 production in LPS-treated endothelial cells.
  • References (33)
  • Citations (1)
#1Yixia Zhao (OSU: Ohio State University)H-Index: 6
#2Minxiang Lei (U of C: University of Chicago)H-Index: 2
Last.Jian Zhang (U of C: University of Chicago)H-Index: 26
view all 6 authors...
13 CitationsSource
#1Elisa Ferretti (Istituto Giannina Gaslini)H-Index: 14
#2Vito Pistoia (Istituto Giannina Gaslini)H-Index: 51
Last.Anna Corcione (Istituto Giannina Gaslini)H-Index: 24
view all 3 authors...
37 CitationsSource
#1C. Raspé (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 1
#2K. HöcherlH-Index: 1
Last.Michael Bucher (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 26
view all 5 authors...
13 CitationsSource
32 CitationsSource
#1Jie Li (Lankenau Institute for Medical Research)H-Index: 4
#2Donglan Zhang (Lankenau Institute for Medical Research)H-Index: 3
Last.Iraimoudi S. Ayene (Thomas Jefferson University)H-Index: 3
view all 5 authors...
14 CitationsSource
#1Brian A. JonesH-Index: 3
#2Maria BeamerH-Index: 3
Last.Salahuddin AhmedH-Index: 15
view all 3 authors...
78 CitationsSource
#1Mi Jeong SungH-Index: 22
#2Duk-Hoon Kim (CBNU: Chonbuk National University)H-Index: 1
Last.Dae Young KwonH-Index: 28
view all 8 authors...
13 CitationsSource
#1Gerald S. Supinski (UK: University of Kentucky)H-Index: 17
#2Wenyi Wang (UK: University of Kentucky)H-Index: 2
Last.Leigh Ann Callahan (UK: University of Kentucky)H-Index: 17
view all 3 authors...
66 CitationsSource
#1Xiaoping Li (Fudan University)H-Index: 2
#2Ying Li (UWO: University of Western Ontario)H-Index: 7
Last.Tianqing Peng (UWO: University of Western Ontario)H-Index: 31
view all 6 authors...
52 CitationsSource
#1Min HeH-Index: 5
#2Shabbir MoochhalaH-Index: 47
Last.Madhav BhatiaH-Index: 48
view all 4 authors...
14 CitationsSource
Cited By1
#1Chor Ho JoH-Index: 5
#2Sua KimH-Index: 6
Last.Gheun-Ho KimH-Index: 28
view all 4 authors...
5 CitationsSource